Ayr Wellness Inc. (AYRWF)
(Delayed Data from OTC)
$0.00 USD
0.00 (-28.57%)
Updated Aug 5, 2025 03:50 PM ET
3-Hold of 5 3
A Value D Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AYRWF 0.00 0.00(-28.57%)
Will AYRWF be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AYRWF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AYRWF
Stryker (SYK) Q2 Earnings and Revenues Beat Estimates
Cresco Labs Inc. (CRLBF) Reports Q1 Loss, Tops Revenue Estimates
AYRWF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Taysha Gene Therapies, Inc. (TSHA) Reports Q1 Loss, Tops Revenue Estimates
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q1 Loss, Tops Revenue Estimates
Verano Holdings Corp. (VRNOF) Reports Q1 Loss, Lags Revenue Estimates
Other News for AYRWF
Trump privately backed marijuana rescheduling since taking office: Scotts Miracle-Gro CEO
AYR Wellness Enters Into Restructuring Support Agreement with Senior Noteholders | AYRWF Stock News
AYR Wellness Announces Further Extension of Limited Waiver Agreement with Senior Noteholders | ...
Ayr Wellness extends limited waiver agreement with senior noteholders
U.S. Senate confirms President Trump’s DEA pick